Source: Osha.gov | Receipt Date: 2020-12-22
6225 West 56th Street, Indianapolis, Indiana, United States
Updated:
Source: Osha.gov | Receipt Date: 2020-12-22
Recent Interesting Reports
Did not order, Texas, USA
2 weeks ago •reported by user-whyx3942
Order, Everett, Massachusetts, EE. UU.
3 weeks ago •reported by user-xzfq7797
Fallacture. com, Colorado, USA
2 weeks ago •reported by user-rfch4519
Scam, Saskatchewan, Canada
1 week ago •reported by user-jczyy898
I ordered a hydrogen bottle from YW Co. Ltd, from Mississauga, ON. and there is no outlet on the bottom of the bottle for any plug in. I emailed
Scam - ketogenesis. com, Las Vegas, NV, USA
2 weeks ago •reported by user-kybcp695
Scam, Texas, USA
3 weeks ago •reported by user-fnhfd224
I received two packages of Verti Bioribose that I have not ordered, Naples, FL, USA
2 weeks ago •reported by user-bkqwv767
Amneal Vancomycin Hydrochloride for Oral Solution - recalled due to super poteny risk, USA
4 weeks ago •source www.fda.gov
Recall notice
Risk Statement: Adult patients who are prescribed the maximum daily dose of up to 2 grams per day of Vancomycin Hydrochloride for oral solution, USP 250 mg/5mL, may receive up to 4 grams of oral vancomycin per day because of the overfilled bottle. Some patients with inflammatory disorders of the intestinal mucosa also may have significant systemic absorption of vancomycin. These patients may be at risk for the development of adverse reactions associated with higher doses of vancomycin oral solution. Worsening renal function could be associated with electrolyte abnormalities such as high potassium leading to cardiac arrest.
The recommended maximum daily dose allowance for this product is up to 2gm/day and patients prescribed a dosing regimen of 500 mg/10mL would exceed this daily allowance, which may be harmful to patients with renal insufficiency. The error occurred during the manual bottle filling stage of manufacturing.
Vancomycin Hydrochloride for Oral Solution, USP, 250mg/5mL, is administered orally for treatment of enterocolitis caused by Staphylococcus aureus (including methicillin-resistant strains) and antibiotic- associated pseudomembranous colitis caused by C. difficile.
The Vancomycin HCl for Oral Solution, USP, 250 mg/5mL subject to the recall, are identified by the NDC numbers stated on the product label. The following lot numbers of Vancomycin Hydrochloride for Oral Solution, USP, 250 mg/5mL are included in this recall.
Vancomycin Hydrochloride for Oral Solution, USP, 250mg/5mL.
- Pack Size: 80 mL, Expiration Date: 09/2025, Lot: 22613003A, NDC No.: 69238-2261-3.
- Pack Size: 150 mL, Expiration Date: 09/2025, Lot: 22613004A, NDC No.: 69238-2261-7.
- Pack Size: 150 mL, Expiration Date: 09/2025, Lot: 22613005A, NDC No.: 69238-2261-7.
- Pack Size: 300 mL, Expiration Date: 09/2025, Lot: 22613005B, NDC No.: 69238-2261-5.
Anyone with an existing inventory of the product being recalled should examine the product and quarantine any of the recalled lots immediately. Retailers who have Vancomycin Hydrochloride for Oral Solution, USP, 250 mg/5mL, which are being recalled, should examine their inventory and cease dispensing any of the impacted lots.
In case you experience harm from this product, it is important to report it. It can help to detect & resolve issues and prevent others from being harmed, and it enables better surveillance. If symptoms persist, seek medical care.
Company name: Amneal Pharmaceuticals, LLC.
Brand name: Amneal
Product recalled: Vancomycin Hydrochloride for Oral Solution, USP, 250 mg/5mL
Reason of the recall: Super potent due to bottles being overfilled
FDA Recall date: March 27, 2024
Source: www.fda.gov
Package received but not ordered, Perth WA, Australia
4 weeks ago •reported by user-nghzd644
Pair of shoes
Sender: U3, 10-12 Wiggs Rd, Riverwood NSW 2210.
Report by
IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)
Visit our learn pages for more helpful information or, email us: support@safelyhq.com